Related Experiment Video
Updated: Jul 5, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
Published on: April 10, 2026
Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides
Ayman Hawrani1, Robin A Howe, Timothy R Walsh
1Department of Cellular and Molecular Medicine, Bristol University, Bristol BS8 1TD, United Kingdom.
Abstract:
We recently described a novel antimicrobial peptide, RTA3, derived from the commensal organism Streptococcus mitis, with strong anti-Gram-negative activity, low salt sensitivity, and minimal mammalian cell toxicity in vitro and in vivo. This peptide conforms to the positively charged, amphipathic helical peptide motif, but has a positively charged amino acid (Arg-5) on the nonpolar face of the helical structure that is induced upon membrane binding. We surmised that disruption of the hydrophobic face with a positively charged residue plays a role in minimizing eukaryotic cell toxicity, and we tested this using a mutant with an R5L substitution. The greatly enhanced toxicity in the mutant peptide correlated with its ability to bind and adopt helical conformations upon interacting with neutral membranes; the wild type peptide RTA3 did not bind to neutral membranes (binding constant reduced by at least 1000-fold). Spectroscopic analysis indicates that disruption of the hydrophobic face of the parent peptide is accommodated in negatively charged membranes without partial peptide unfolding. These observations apply generally to amphipathic helical peptides of this class as we obtained similar results with a peptide and mutant pair (Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E., Vasil, M. L., and Hodges, R. S. (2005) J. Biol. Chem. 280, 12316-12329) having similar structural properties. In contrast to previous interpretations, we demonstrate that these peptides simply do not bind well to membranes (like those of eukaryotes) with exclusively neutral lipids in their external bilayer leaflet. We highlight a significant role for tryptophan in promoting binding of amphipathic helical peptides to neutral bilayers, augmenting the arsenal of strategies to reduce mammalian toxicity in antimicrobial peptides.
Insights
A novel antimicrobial peptide, RTA3, shows reduced toxicity to mammalian cells by not binding well to neutral membranes. This finding offers strategies for developing safer antimicrobial peptides.
Area of Science:
- Biochemistry
- Microbiology
- Molecular Biology
Background:
- A novel antimicrobial peptide, RTA3, from Streptococcus mitis exhibits potent activity against Gram-negative bacteria with low salt sensitivity and minimal toxicity.
- RTA3 possesses a positively charged, amphipathic helical structure, but uniquely features a positively charged residue (Arg-5) on its nonpolar face upon membrane binding.
Purpose of the Study:
- To investigate the role of the positively charged residue on the nonpolar face of RTA3 in minimizing mammalian cell toxicity.
- To explore the binding interactions of RTA3 and its mutant with neutral and negatively charged membranes.
Main Methods:
- Comparative analysis of RTA3 and an R5L mutant peptide with varying membrane compositions.
- Spectroscopic techniques to analyze peptide conformation and membrane binding.
- Determination of binding constants to neutral and negatively charged lipid bilayers.
Main Results:
- The R5L mutant peptide exhibited significantly enhanced mammalian cell toxicity compared to wild-type RTA3.
- Enhanced toxicity of the mutant correlated with increased binding and helical adoption upon interaction with neutral membranes.
- Wild-type RTA3 demonstrated significantly reduced binding (over 1000-fold decrease) to neutral membranes, while accommodating negative charges without unfolding.
- Tryptophan residues were identified as crucial for promoting amphipathic helical peptide binding to neutral bilayers.
Conclusions:
- The presence of a positively charged residue on the nonpolar face of amphipathic helical peptides, like RTA3, is a key factor in reducing eukaryotic cell toxicity.
- These peptides exhibit poor binding to neutral membranes, characteristic of eukaryotic cell membranes, thus contributing to their safety profile.
- Understanding these binding specificities provides a strategic approach for designing safer and more effective antimicrobial peptides.
More Related Videos
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents
Clinical Significance of Antibiotic Resistance